Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation

Ítems similars

• Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
  per: Lee, Sang Hoon, et al.
  Publicat: (2020)
• Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer
  per: Lee, Sang Hoon, et al.
  Publicat: (2020)
• Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
  per: Kim, Eun Young, et al.
  Publicat: (2018)
• Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
  per: Taehee Kim, et al.
  Publicat: (2019-12-01)
• Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
  per: Kim, Taehee, et al.
  Publicat: (2019)